On this episode of Stock Movers:
- Pfizer (PFE) shares fall after Pfizer forecasted little to no sales growth next year as the drugmaker undertakes an effort to refresh its pipeline of hit drugs with a series of pricey acquisitions.
- Paypal (PYPL) shares gain after the company applied to become a bank in the US by submitting applications to the Federal Deposit Insurance Corp. and the Utah Department of Financial Institutions.
- Stubhub (STUB) shares fall after the company received a downgrade at Citizens, which predicts that the ticketing platform will face more robust competition in 2026 and flagged headwinds from regulation

On this episode of Stock Movers: - Pfizer (PFE) shares fall after Pfizer forecasted little to no sales growth next year as the drugmaker undertakes an effort to refresh its pipeline of hit drugs with a series of pricey acquisitions. - Paypal (PYPL) shares gain after the company applied to become a bank in the US by submitting applications to the Federal Deposit Insurance Corp. and the Utah Department of Financial Institutions. - Stubhub (STUB) shares fall after the company received a downgrade at Citizens, which predicts that the ticketing platform will face more robust competition in 2026 and flagged headwinds from regulation

Listen for five-minute conversations on today's biggest winners and losers in the stock market. Subscribe for analysis on the companies making news on Wall Street.

Listen for five-minute conversations on today's biggest winners and losers in the stock market. Subscribe for analysis on the companies making news on Wall Street.

Listen for news on today's biggest winners and losers in the stock market.

Stock Movers

Pfizer Falls, Paypal Gains, Stubhub Falls After Ratings Downgrade

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/1e1c6df1-51ba-4342-8431-b3b50110707f/transcript

On this episode of Stock Movers:
- General Mills (GIS) shares rise 1.6% after the food company’s second-quarter results beat Street expectations. A highlight of the report was positive volume growth in the North America Retail segment. The company maintained its annual guidance ranges, despite the beat, given persistent consumer pressures. 
- Oracle (ORCL) shares are down 5.3% on Wednesday, after the Financial Times reported that Blue Owl Capital will not back a $10 billion deal for the software giant’s next data center. Subsequently, an Oracle spokesperson said that Blue Owl is out of the data center deal, but that it remains on schedule. 
- Canaccord downgraded Udemy (UDMY) to Hold from Buy with a $7 price target after the company announced a merger with Coursera

On this episode of Stock Movers: - General Mills (GIS) shares rise 1.6% after the food company&rsquo;s second-quarter results beat Street expectations. A highlight of the report was positive volume growth in the North America Retail segment. The company maintained its annual guidance ranges, despite the beat, given persistent consumer pressures. - Oracle (ORCL) shares are down 5.3% on Wednesday, after the Financial Times reported that Blue Owl Capital will not back a $10 billion deal for the software giant&rsquo;s next data center. Subsequently, an Oracle spokesperson said that Blue Owl is out of the data center deal, but that it remains on schedule. - Canaccord downgraded Udemy (UDMY) to Hold from Buy with a $7 price target after the company announced a merger with Coursera

General Mills Rises, Oracle Falls, Udemy Downgraded

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/56a8b4a4-bcf8-4cf8-9086-b3b6017a2f89/transcript

Listen for comprehensive cross-platform coverage of the US market close as heard on Bloomberg Television, Bloomberg Radio, and YouTube with Romaine Bostick, Katie Greifeld, Tim Stenovec and Carol Massar.
On this episode of Stock Movers:
- Micron (MU) the largest US maker of computer memory chips, gave an upbeat forecast for the current quarter, a sign that surging demand and supply shortages are allowing the company to charge more for products. Fiscal second-quarter revenue will be $18.3 billion to $19.1 billion, the company said in a statement Wednesday. Analysts had estimated $14.4 billion on average for the period. Excluding some items, profit will be $8.22 to $8.62 a share, compared with a projection of $4.71. Micron shares rose about 4% in late trading after the results were released. The stock was already up 168% this year, closing at $225.71 on Wednesday.
- Medline (MDLN) shares surged 41% in their trading debut, after the medical supplier raised $6.26 billion in the year’s biggest initial public offering. The shares closed at $41 each on Wednesday in New York, versus the IPO price of $29. Medline, which counts Blackstone Inc., Carlyle Group Inc. and Hellman & Friedman among its backers, sold 216 million shares in an upsized offering that priced near the top of the marketed range. The trading gives the company a market value of about $55 billion, based on the shares listed in its regulatory filings.
- Nvidia (NVDA) settled a lawsuit involving a former engineer who had inadvertently revealed autonomous driving trade secrets that he stole from a previous employer. The accord between the Silicon Valley artificial intelligence giant and a German unit of Paris-based Valeo SE was disclosed in a filing in federal court in San Jose, California. No details of the agreement were provided. A trial set for next month was canceled. Nvidia shares were lower in trading on Wednesday.

Listen for comprehensive cross-platform coverage of the US market close as heard on Bloomberg Television, Bloomberg Radio, and YouTube with Romaine Bostick, Katie Greifeld, Tim Stenovec and Carol Massar. On this episode of Stock Movers: - Micron (MU) the largest US maker of computer memory chips, gave an upbeat forecast for the current quarter, a sign that surging demand and supply shortages are allowing the company to charge more for products. Fiscal second-quarter revenue will be $18.3 billion to $19.1 billion, the company said in a statement Wednesday. Analysts had estimated $14.4 billion on average for the period. Excluding some items, profit will be $8.22 to $8.62 a share, compared with a projection of $4.71. Micron shares rose about 4% in late trading after the results were released. The stock was already up 168% this year, closing at $225.71 on Wednesday. - Medline (MDLN) shares surged 41% in their trading debut, after the medical supplier raised $6.26 billion in the year&rsquo;s biggest initial public offering. The shares closed at $41 each on Wednesday in New York, versus the IPO price of $29. Medline, which counts Blackstone Inc., Carlyle Group Inc. and Hellman &amp; Friedman among its backers, sold 216 million shares in an upsized offering that priced near the top of the marketed range. The trading gives the company a market value of about $55 billion, based on the shares listed in its regulatory filings. - Nvidia (NVDA) settled a lawsuit involving a former engineer who had inadvertently revealed autonomous driving trade secrets that he stole from a previous employer. The accord between the Silicon Valley artificial intelligence giant and a German unit of Paris-based Valeo SE was disclosed in a filing in federal court in San Jose, California. No details of the agreement were provided. A trial set for next month was canceled. Nvidia shares were lower in trading on Wednesday.

Closing Bell: Micron Gives Rosy Forecast, Medline Surges in Debut, Nvidia Sinks

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/e971fff8-350f-4f7b-8997-b3b6015fec30/transcript

On this episode of Stock Movers:
- Oracle (ORCL) shares are down 5.3% on Wednesday, after the Financial Times reported that Blue Owl Capital will not back a $10 billion deal for the software giant’s next data center. Subsequently, an Oracle spokesperson said that Blue Owl is out of the data center deal, but that it remains on schedule. 
- Lennar (LEN) shares fall 3.8% in premarket trading after the homebuilder forecast 1Q orders, deliveries and margins all below expectations, signaling strains on the housing market despite a lower interest rate. The builder also posted lower-than-expected orders and margins for 4Q. Keep an eye on shares of peers including DR Horton, PulteGroup and Toll Brothers.
- Medline (MDLN) shares surged 30% in their trading debut, after the medical supplier raised $6.26 billion in the year’s biggest initial public offering.

On this episode of Stock Movers: - Oracle (ORCL) shares are down 5.3% on Wednesday, after the Financial Times reported that Blue Owl Capital will not back a $10 billion deal for the software giant&rsquo;s next data center. Subsequently, an Oracle spokesperson said that Blue Owl is out of the data center deal, but that it remains on schedule. - Lennar (LEN) shares fall 3.8% in premarket trading after the homebuilder forecast 1Q orders, deliveries and margins all below expectations, signaling strains on the housing market despite a lower interest rate. The builder also posted lower-than-expected orders and margins for 4Q. Keep an eye on shares of peers including DR Horton, PulteGroup and Toll Brothers. - Medline (MDLN) shares surged 30% in their trading debut, after the medical supplier raised $6.26 billion in the year&rsquo;s biggest initial public offering.

Oracle Drops, Lennar Falls, Medline Surges

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/046dece7-d459-4ef5-a33e-b3b6014c2c63/transcript

Pfizer Falls, Paypal Gains, Stubhub Falls After Ratings Downgrade

In 1 playlist(s)

Stock Movers

Social links

Follow podcast

Recent clips